eIF2α+/− mice exhibited a reduction in the occurrence of diverse tissue tumors and hyperplasia, particularly seminal vesicle hyperplasia (from 81.25% to 14.29%) and lipoma (from 37.5% to 7.14%) (Figure 5p). This evidence concerns the gene EIF2A and lipoma.